MRK vs SMCI: Which Is the Better Buy?
Side-by-side comparison of Merck & Co., Inc. and Super Micro Computer, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-20.
Merck & Co., Inc. · Healthcare
$114.27
+3.3% upside to fair value
Grade C
High Quality
VS
Super Micro Computer, Inc. · Technology
$34.66
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
SMCI has more upside to fair value
(+45.0%).
SMCI trades at a lower forward P/E
(11.6x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRK |
SMCI |
| Current Price |
$114.27 |
$34.66 |
| Fair Value Estimate |
$118.00 |
$50.26 |
| Upside to Fair Value |
+3.3%
|
+45.0%
|
| Market Cap |
$282.2B |
$20.8B |
| Forward P/E |
22.4x
|
11.6x
|
| EV / EBITDA |
13.5x
|
17.9x
|
| Price / Sales |
4.3x
|
0.6x
|
| Price / FCF |
20.2x
|
-3.0x
|
| Revenue Growth YoY |
+5.0%
|
+122.7%
|
| Gross Margin |
81.9%
|
8.4%
|
| Operating Margin |
27.5%
|
4.5%
|
| Return on Equity |
5.6%
|
26.0%
|
| Dividend Yield |
2.91% |
0% |
| FCF Yield |
4.95%
|
—
|
| Analyst Consensus |
Overweight
|
Hold
|
Investment Thesis
Merck delivered a clean Q1 2026 operational beat on April 30, with revenue of 16.3 billion dollars growing 5 percent year over year and Keytruda sales rising 12 percent to 8.0 billion dollars. The reported loss of 1.28 dollars per share, though better than the negative 1.47 dollar consensus estimate, reflected a 3.62 dollar per share IPR and D charge tied to the Cidara Therapeutics acquisition an…
Super Micro Computer, Inc. is a technology company specializing in server and storage systems, with a dominant 97% revenue share from this segment driven by AI and cloud infrastructure demand. The company benefits from a founder-led management team with deep engineering expertise and strong insider ownership of approximately 46-48%, aligning interests with shareholders. Despite explosive revenue …
Accumulation Zones
| Metric |
MRK |
SMCI |
| Zone Low |
$88.50 |
$37.70 |
| Zone High |
$100.30 |
$42.72 |
| In Buy Zone? |
No
|
Yes
|